Brian Vadasz

Platelet gene expression and function in patients with COVID-19

Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7

Comprehensive analysis of platelet glycoprotein Ibα ectodomain glycosylation

Deciphering O -glycoprotease substrate preferences with O-Pair Search

Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis

Targeted glycan degradation potentiates the anticancer immune response in vivo

Reading the glyco-code: New approaches to studying protein–carbohydrate interactions

On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans

Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway

Small RNAs are modified with N-glycans and displayed on the surface of living cells

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses

Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals

Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia